http://money.cnn.com/news/newsfeeds/articles/marketwire/0584868.htm
<p>February 08, 2010: 12:00 PM E</p> <p>Stem Cell Therapy International, Inc. (OTCBB: SCII) announced that Histostem Ltd. of South Korea ("Histostem") has participated in a study resulting in the successful treatment of spinal cord injury in dogs through the use of Multipotent Stem Cells (MSCs) derived from Human Umbilical Cord Blood (HUCB). The study, a collaborative effort between a team of doctors from the Departments of Veterinary Surgery and Veterinary Anatomy at Konkuk University,…</p>